Drug Development

Second clinical trial for bone fractures therapy initiated in Spain

Published in Biotech Business Week, January 9th, 2006

Aastrom Biosciences, Inc., (ASTM) announced the initiation of a new bone grafting clinical trial sponsored by Fundacion Teknon and Institut de Terapia Regenerativa Tisular (ITRT) at Hospital de Barcelona S.C.I.A.S., Hospital General de l'Hospitalet and Centro Medico Teknon located in Barcelona, Spain.

The phase I/II multicenter clinical trial has been approved by the Spanish Drug Agency (AEMPS) and is designed to further demonstrate the safety and effectiveness of the company's Tissue Repair Cells (TRCs) to regenerate new, healthy bone in the repair of long bone fractures.

This study follows a successful pilot trial that included 5 patients conducted...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2006-01-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry